Autologous CD19 CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Autologous CD19 CAR-T cell therapy, covering 2025-05-29 to 2025-06-05. Get the full timeline:
Most recent: Clinical Trial Update: T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia [Phase 1]